Cost-opportunity analysis in clinical oncology: from the 'wild far-west' to a correct integration of the disciplines, avoiding the 'war of the worlds'

Ann Oncol. 2006 May;17(5):876-7; reply 877-8. doi: 10.1093/annonc/mdj086. Epub 2005 Nov 29.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols* / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols* / economics
  • Clinical Trials as Topic
  • Cost-Benefit Analysis
  • Drug Costs
  • Economics, Pharmaceutical*
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / economics
  • Palliative Care